Periodicals Tyler says cyberattack against it used ransomware, Reuters reports » Amazon.com $3,019.70 / +21.05 (+0.70%) AMZN Tyler Technologies $334.25 / -4.28 (-1.26%) TYL Tyler Technologies (TYL)… Tyler Technologies (TYL) said that the cyberattack against the company disclosed earlier this week used ransomware, which encrypts company files and demands payment to decrypt them again, Reuters' Joseph Menn reports. The company told Reuters that attacker only access internal networks, adding that the hack had no impact on the software it hosts for clients. Tyler added that the software it sells that displays election results is hosted by Amazon (AMZN) and therefore was not at risk, Menn notes. "We have confirmed that the malicious software the intruder used was ransomware. Because this is an active investigation, we will not provide any additional specifics relating to our incident response or our investigation at this time," Tyler said. Reference Link Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Events

Options

Technical Analysis TYL

AMZN TYL Tyler Technologies $334.25 / -4.28 (-1.26%) 09/01/20 Tyler, Cerner enter pact to aid state health departments with Medicare reporting 07/28/20 Tyler Technologies signs agreement with NC for electronic warrant system 07/23/20 Tyler Technologies signs agreement with Jacksonville Sheriff's Office for RMS 07/21/20 Tyler Technologies signs agreement for school transportation solutions with SCDE AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 09/24/20 Amazon announces new Echo, Echo Dot, Echo Dot Kids Edition 09/24/20 Amazon announces new Fire TV Stick, Fire TV Stick Lite 09/24/20 Amazon introduces Luna cloud gaming service 09/24/20 Amazon introduces eero 6 series mesh Wi-Fi systems starting at $129 AMZN

TYL AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 09/24/20 Piper Sandler Amazon.com assumed with an Overweight at Piper Sandler 09/24/20 Morgan Stanley Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley 09/23/20 Piper Sandler Amazon Care program expansion not a threat to Teladoc, says Piper Sandler 09/23/20 Benchmark Benchmark says Microsoft partnership can be 'big driver' for Kratos TYL Tyler Technologies $334.25 / -4.28 (-1.26%) 09/22/20 Baird Baird upgrades Tyler Technologies to Outperform on post-COVID opportunity 09/22/20 Baird Tyler Technologies upgraded to Outperform from Neutral at Baird 07/31/20 Northland Tyler Technologies price target raised to $400 from $350 at Northland 07/28/20 Fly Intel: Top five analyst downgrades TYL

AMZN TYL Tyler Technologies $334.25 / -4.28 (-1.26%) 07/29/20 Tyler Technologies sees Q3 adjusted EPS $5.30-$5.50, consensus $5.26 07/29/20 Tyler Technologies reports Q2 adjusted EPS $1.38, consensus $1.20 04/29/20 Tyler Technologies suspends guidance amid COVID-19 outbreak 04/29/20 Tyler reports Q1 adjusted EPS $1.25, consensus $1.25 AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B 07/30/20 Amazon.com reports Q2 EPS $10.30, consensus $1.46 07/30/20 Notable companies reporting after market close 07/14/20 ChannelAdvisor announces advanced options for advertisers in Amazon.com AMZN AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 09/24/20 Amazon says Ring Car Connect will work with Teslas 09/24/20 Possible Amazon game controller appears in FCC filings, Verge says 09/23/20 Amazon denies formal connection to 'Prime Bike,' The Verge reports 09/22/20 GameStop spikes after investor plans to make it Amazon rival, Bloomberg says AMZN AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 09/24/20 Fly Intel: Wall Street's top stories for Thursday 09/22/20 Fly Intel: What to watch in Nike's earnings report 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street 09/22/20 Fly Intel: Pre-market Movers AMZN AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 08/18/20 Early notable gainers among liquid option names on August 18th 07/31/20 Early notable gainers among liquid option names on July 31st 07/20/20 Early notable gainers among liquid option names on July 20th 06/26/20 Unusually active option classes on open June 26th AMZN AMZN Amazon.com $3,019.70 / +21.05 (+0.70%) 05/01/20 On The Fly: Weekly technical notes for S&P 500

Conference/Events Albemarle participates in a conference call with UBS » Albemarle $83.17 / +2.8 (+3.48%) ALB Global Head of Mining… Global Head of Mining Research Lawcock and North American Chemical Equity Research Director Roberts holds a conference call with management on September 24 at 7 pm hosted by UBS. Webcast Link Show Hide Related Items >> << Company News

Street Research

Earnings

Periodicals

On The Fly

Events

Options ALB Albemarle $83.17 / +2.8 (+3.48%) 09/23/20 Albemarle falls -10.4% 09/02/20 Albemarle selected by Department of Energy for two projects 04/20/20 Albemarle names J. Kent Masters Chairman, President and CEO ALB Albemarle $83.17 / +2.8 (+3.48%) 09/23/20 Raymond James Market overreacting to Musk's lithium comments, says Raymond James 09/23/20 Morgan Stanley Morgan Stanley says Tesla battery technologies 'bearish for lithium' 09/23/20 Baird Albemarle designated as a bearish Fresh Pick at Baird 09/22/20 Evercore ISI Albemarle initiated with an Underperform at Evercore ISI ALB Albemarle $83.17 / +2.8 (+3.48%) 08/05/20 Albemarle sees Q3 revenue $700M-$775M, consensus $717.55M 08/05/20 Albemarle reports Q2 adjusted EPS 86c, consensus 73c 05/06/20 Albemarle withdraws 2020 guidance 05/06/20 Albemarle sees Q2 revenue $700M-$775M, consensus $775.7M ALB Albemarle $83.17 / +2.8 (+3.48%) 09/10/20 Albemarle locked in dispute with Chile over reserves information, Reuters says 06/08/20 'Million-mile' battery ready to make says Tesla battery producer, Bloomberg says 05/28/20 Albemarle wants control of Australia's Greenbushes lithium mine, Reuters says ALB Albemarle $83.17 / +2.8 (+3.48%) 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day 05/06/20 Fly Intel: After-Hours Movers ALB Albemarle $83.17 / +2.8 (+3.48%) 07/13/20 Early notable gainers among liquid option names on July 13th 06/01/20 Albemarle put volume heavy and directionally bearish

On The Fly Fly Intel: After-Hours Movers » China Finance Online $7.48 / -0.27 (-3.48%) JRJC AAR Corp. $17.84 / +0.36 (+2.06%) AIR CalAmp $7.90 / -0.14 (-1.74%) CAMP Vail Resorts $224.35 / -3.98 (-1.74%) MTN Colony Capital $2.34 / -0.03 (-1.27%) CLNY Genfit $3.67 / -0.28 (-7.09%) GNFT Altimmune $12.03 / -0.5 (-3.99%) ALT Novavax $102.48 / +0.92 (+0.91%) NVAX Cassava Sciences $9.72 / -0.065 (-0.66%) SAVA Bristol-Myers $58.24 / -0.76 (-1.29%) BMY Ibex $10.95 / +0.7 (+6.83%) IBEX Costco $347.25 / +2.67 (+0.77%) COST Check out this evening's… Open Full Text Show Hide Related Items >> << Company News

Street Research

Earnings

Syndicate

Periodicals

On The Fly

Events

Options SAVA

NVAX

MTN

JRJC

IBEX

GNFT

COST

CLNY

CAMP

BMY

ALT

AIR SAVA Cassava Sciences $9.72 / -0.065 (-0.66%) 09/24/20 Cassava Sciences CEO buys 10K shares of common stock 09/21/20 Cassava Sciences up nearly 20% after purchase of stock by director 09/18/20 Cassava Sciences up 26% in pre-market after insider purchase 09/14/20 Cassava Sciences announces results of Phase 2b study of sumifilam NVAX Novavax $102.48 / +0.92 (+0.91%) 09/24/20 Novavax initiates Phase 3 NVX-CoV2373 COVID-19 vaccine candidate trial 09/22/20 Canada reports agreements with Sanofi and GSK for up to 72M COVID vaccine doses 09/15/20 Novavax enters COVID-19 vaccine manufacturing agreement with SIIPL 09/08/20 COVID vaccine makers pledge to only seek approval after Phase 3 testing MTN Vail Resorts $224.35 / -3.98 (-1.74%) 09/24/20 Vail Resorts: Season pass sales through September 18 up about 18% in units 09/22/20 Vail Resorts, PepsiCo expand partnership focused on waste reduction 06/09/20 Ron Baron names Choice Hotels, Vail Resorts, Hyatt as continued holdings 04/27/20 Vail Resorts sees reduction in FY20 Resort Reported EBITDA of about $115M JRJC China Finance Online $7.48 / -0.27 (-3.48%) 07/16/20 China Finance Online in pact with Dow Jones for Chinese-language news 07/15/20 China Finance Online announces newswire partnership agreement with Dow Jones 04/28/20 China Finance Online announces extension for reporting Q4 results IBEX Ibex $10.95 / +0.7 (+6.83%) 09/15/20 Ibex brings 400 jobs to Ocho Rios in Jamaica GNFT Genfit $3.67 / -0.28 (-7.09%) 09/24/20 Genfit announces first patient visit for ELATIVE study 08/05/20 Genfit announces publication of NIS4 technology in Lancet 07/23/20 Genfit discontinues Phase 3 elafibranor trial in steatohepatitis, fibrosis 06/29/20 Intercept plunges, drags down some NASH peers after CRL from FDA COST Costco $347.25 / +2.67 (+0.77%) 09/24/20 Costco shares slip 2.3% after Q4 results 09/02/20 Costco reports total August SSS up 13.2% 08/21/20 Costco CFO sells 1,754 common shares 08/17/20 Tiffany 'disappointed' in appeals court reversing Costco infringement ruling CLNY Colony Capital $2.34 / -0.03 (-1.27%) 09/24/20 Colony Capital to sell six hospitality portfolios to Highgate for $2.8B 07/13/20 Colony Capital: Wafra affiliates to acquire minority stake in Digital Colony 07/07/20 Colony Capital forms strategic partnership with Vantage Data Centers 07/01/20 Colony Capital effects CEO succession plan, appoints CEO Marc Ganzi to board CAMP CalAmp $7.90 / -0.14 (-1.74%) 09/24/20 CalAmp up 5% to $8.30 after reporting Q2 results 08/04/20 CalAmp extends relationship with Caterpillar 07/08/20 CalAmp appoints Jeff Gardner as CEO 06/18/20 CalAmp's LoJack Mexico signs partnership agreement with Overhaul Group BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 09/24/20 Bristol-Myers announces Phase 3 Opdivo trial meets primary endpoints 09/22/20 Bristol-Myers, bluebird bio get FDA priority review for Ide-cel 09/21/20 Bristol-Myers announces first results from Phase 3 CheckMate -577 trial 09/21/20 Bristol-Myers announces primary results from CheckMate -649 trial ALT Altimmune $12.03 / -0.5 (-3.99%) 09/24/20 Altimmune up over 7% at $12.90 after disclosing passive stake by D.E. Shaw 09/24/20 D.E. Shaw reports 5.0% passive stake in Altimmune 09/01/20 Altimmune completes multiple dose toxicity, toxicokinetic studies of ALT-801 08/26/20 Altimmune presents preclinical data on ALT-801 for NASH AIR AAR Corp. $17.84 / +0.36 (+2.06%) 09/01/20 AAR Corp. subsidiary Airinmar signs services agreement with Frontier Airlines 09/01/20 AAR Corp. subsidiary Airinmar signs services agreement with Frontier Airlines 08/25/20 AAR Corp. announces paartnership with CSW to reduce labor shortage 07/27/20 AAR Corp. awarded three-year MRO contract with Royal Netherlands Air Force JRJC

AIR

CAMP

MTN

CLNY

GNFT

ALT

NVAX

SAVA

BMY

IBEX

COST JRJC China Finance Online $7.48 / -0.27 (-3.48%) AIR AAR Corp. $17.84 / +0.36 (+2.06%) 07/15/20 Truist SunTrust downgrades select commercial aviation supply stocks 07/15/20 Truist AAR Corp. downgraded to Hold from Buy at SunTrust 06/30/20 Canaccord AAR Corp. upcoming results focused on second half recovery, says Canaccord 03/18/20 Canaccord AAR Corp. price target lowered to $25 from $55 at Canaccord CAMP CalAmp $7.90 / -0.14 (-1.74%) 04/17/20 Jefferies CalAmp upgraded to Buy at Jefferies with downside case seen as priced in 04/17/20 Jefferies CalAmp upgraded to Buy from Hold at Jefferies 03/26/20 JPMorgan CalAmp price target lowered to $9 from $12 at JPMorgan 03/06/20 Canaccord CalAmp price target lowered to $12 from $17 at Canaccord MTN Vail Resorts $224.35 / -3.98 (-1.74%) 09/11/20 Deutsche Bank Vail Resorts price target raised to $204 from $174 at Deutsche Bank 08/31/20 Fly Intel: Top five analyst downgrades 08/31/20 KeyBanc KeyBanc downgrades Vail Resorts on concerns over resort model 08/31/20 KeyBanc Vail Resorts downgraded to Sector Weight from Overweight at KeyBanc CLNY Colony Capital $2.34 / -0.03 (-1.27%) 06/04/20 B. Riley FBR Colony Capital price target lowered to $4 from $5 at B. Riley FBR 03/11/20 B. Riley FBR B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy GNFT Genfit $3.67 / -0.28 (-7.09%) 08/05/20 H.C. Wainwright Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright 07/23/20 H.C. Wainwright Genfit price target lowered to $8 from $11 at H.C. Wainwright 07/23/20 Fly Intel: Top five analyst upgrades 07/23/20 Stifel Genfit upgraded to Buy from Hold at Stifel ALT Altimmune $12.03 / -0.5 (-3.99%) 09/22/20 Piper Sandler Altimmune nearing two 'key stock-moving events,' says Piper Sandler 09/09/20 Piper Sandler Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold 08/25/20 Piper Sandler Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler 08/25/20 JMP Securities Altimmune's AdCOVID to have 'unique advantages' over other vaccines, says JMP NVAX Novavax $102.48 / +0.92 (+0.91%) 09/15/20 B. Riley FBR Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR 09/09/20 B. Riley FBR Astra trial hold opens window for other vaccine candidates, says B. Riley FBR 09/08/20 B. Riley FBR Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR 09/03/20 Cantor Fitzgerald Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate SAVA Cassava Sciences $9.72 / -0.065 (-0.66%) 09/23/20 H.C. Wainwright Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright 09/14/20 Maxim Cassava upgraded to Buy at Maxim after second analysis of AD drug data 09/14/20 Maxim Cassava Sciences upgraded to Buy from Hold at Maxim 05/18/20 H.C. Wainwright Cassava Sciences downgraded to Neutral from Buy at H.C. Wainwright BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 09/22/20 Oppenheimer Bluebird Bio review timeline consistent with expectations, says Oppenheimer 08/25/20 Piper Sandler Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler 08/06/20 Citi Investors can refocus on Bristol-Myers story after Eliquis win, says Citi 07/28/20 Mizuho Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho IBEX Ibex $10.95 / +0.7 (+6.83%) 09/11/20 Piper Sandler Ibex selloff brings valuation 'disconnect,' says Piper Sandler 09/01/20 Truist Ibex initiated with a Buy at Truist 09/01/20 Baird Baird starts Ibex with Outperform, sees above industry growth profile 09/01/20 Baird Ibex initiated with an Outperform at Baird COST Costco $347.25 / +2.67 (+0.77%) 09/04/20 JPMorgan Costco price target raised to $405 from $365 at JPMorgan 09/03/20 RBC Capital Costco price target raised to $400 from $381 at RBC Capital 09/03/20 Oppenheimer Costco price target raised to $400 from $380 at Oppenheimer 09/03/20 Stifel Costco price target raised to $375 from $360 at Stifel SAVA

NVAX

MTN

JRJC

IBEX

COST

CLNY

CAMP

BMY

ALT

AIR SAVA Cassava Sciences $9.72 / -0.065 (-0.66%) 08/12/20 Cassava Sciences reports Q2 EPS (5c) vs. (6c) last year 05/06/20 Cassava Sciences reports Q1 EPS (5c) vs. (8c) last year 03/26/20 Cassava Sciences reports Q4 EPS (8c), two est. (13c) NVAX Novavax $102.48 / +0.92 (+0.91%) 08/14/20 Novavax says UK to purchase 60M doses of NVX-CoV2373 vaccine candidate 08/10/20 Novavax reports Q2 EPS (30c), consensus (42c) 05/11/20 Novavax reports Q1 EPS (58c), consensus (78c) MTN Vail Resorts $224.35 / -3.98 (-1.74%) 09/24/20 Vail Resorts not providing FY21 guidance at this time 09/24/20 Vail Resorts reports Q4 EPS ($3.82) , consensus ($3.43) 09/24/20 Notable companies reporting after market close 06/04/20 Vail Resorts reports Q3 EPS $3.74, consensus $3.28 JRJC China Finance Online $7.48 / -0.27 (-3.48%) 09/24/20 China Finance Online reports Q2 EPS (65c) vs. ($1.29) last year IBEX Ibex $10.95 / +0.7 (+6.83%) 09/24/20 Ibex sees FY21 revenue $431M-$435M, consensus $443.06M 09/24/20 Ibex reports Q4 EPS (29c), consensus 16c COST Costco $347.25 / +2.67 (+0.77%) 09/24/20 Costco reports Q4 EPS $3.13, consensus $2.83 06/03/20 Costco reports May net sales of $12.55B, up 7.5% from $11.67B last year 05/28/20 Costco reports Q3 EPS $1.89, consensus $2.04 CLNY Colony Capital $2.34 / -0.03 (-1.27%) 08/07/20 Colony Capital reports Q2 core FFO (4c) vs. 13c last year 05/08/20 Colony Capital reports Q1 core FFO (4c), one estimate 6c CAMP CalAmp $7.90 / -0.14 (-1.74%) 09/24/20 CalAmp not providing Q3 guidance 09/24/20 CalAmp reports Q2 adjusted EPS (3c), consensus 0c 06/25/20 CalAmp not providing Q2 guidance 06/25/20 CalAmp reports Q1 adjusted EPS 2c, consensus (5c) BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 08/06/20 Bristol-Myers raises FY20 non-GAAP EPS view to $6.10-$6.25 from $6.00-$6.20 08/06/20 Bristol-Myers reports Q2 non-GAAP EPS $1.63, consensus $1.48 08/05/20 Notable companies reporting before tomorrow's open ALT Altimmune $12.03 / -0.5 (-3.99%) 03/27/20 Altimmune reports FY19 EPS ($1.60), one est. ($1.52) AIR AAR Corp. $17.84 / +0.36 (+2.06%) 09/24/20 AAR Corp. reports Q1 EPS 17c, consensus (5c) 07/21/20 AAR Corp. does not provide FY21 guidance 07/21/20 AAR Corp. reports Q4 EPS 26c, consensus (23c) NVAX MTN COST CLNY BMY NVAX Novavax $102.48 / +0.92 (+0.91%) 09/23/20 U.K. to test vaccines on volunteers deliberately infected with COVID, FT reports 09/23/20 EU, Novavax close to concluding preliminary talks on COVID vaccine, Reuters says 09/23/20 EU, Novavax close to concluding preliminary talks on COVID vaccine, Reuters says 09/22/20 FDA to announce tougher standards for coronavirus vaccine, WaPo says MTN Vail Resorts $224.35 / -3.98 (-1.74%) 08/24/20 Capacity restrictions amid ski season likely to hurt Vail Resorts, WSJ reports COST Costco $347.25 / +2.67 (+0.77%) 09/01/20 Online retailer Boxed exploring $1B sale, Reuters reports 08/11/20 Walmart, Instacart partner for same-day delivery in the U.S., CNBC reports 08/04/20 Walmart delays launch of Walmart+ once again, Recode reports 05/28/20 Notable companies reporting after market close CLNY Colony Capital $2.34 / -0.03 (-1.27%) 08/24/20 Real-estate investors skip loan payments, while raising billions, Bloomberg says BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 08/06/20 Trump to order government to buy certain drugs from U.S., USA Today says 07/24/20 President Trump expected to sign drug pricing executive orders, WaPo reports SAVA NVAX MTN JRJC IBEX GNFT COST CAMP BMY ALT SAVA Cassava Sciences $9.72 / -0.065 (-0.66%) 09/21/20 Fly Intel: After-Hours Movers 09/18/20 Fly Intel: Pre-market Movers 05/15/20 Fly Intel: Pre-market Movers NVAX Novavax $102.48 / +0.92 (+0.91%) 09/09/20 AstraZeneca COVID vaccine pause seen as 'mixed blessing' for competitors 09/08/20 Fly Intel: Wall Street's top stories for Tuesday 09/08/20 Fly Intel: Wall Street's top stories at midday MTN Vail Resorts $224.35 / -3.98 (-1.74%) 08/31/20 Beyond Meat upgrade, Walmart downgrade among today's top calls on Wall Street 06/04/20 Fly Intel: After-Hours Movers JRJC China Finance Online $7.48 / -0.27 (-3.48%) 09/24/20 Fly Intel: After-Hours Movers IBEX Ibex $10.95 / +0.7 (+6.83%) 08/09/20 Opening Day: Quicken Loans parent raises only $1.8B in IPO 08/02/20 Opening Day: Chinese EV maker Li Auto soars 50% in IPO 07/26/20 Opening Day: Apple Enterprise Management software provider Jamf soars in debut GNFT Genfit $3.67 / -0.28 (-7.09%) 05/12/20 Fly Intel: Wall Street's top stories for Tuesday 05/12/20 Fly Intel: Wall Street's top stories at midday 05/12/20 CymaBay jumps, Genfit plunges as Wall Street digests NASH news COST Costco $347.25 / +2.67 (+0.77%) 09/02/20 Fly Intel: After-Hours Movers 09/02/20 Neptune Wellness CEO talks Unilever partnership in Fly exclusive interview 08/17/20 Fly Intel: What to watch in Walmart's earnings report CAMP CalAmp $7.90 / -0.14 (-1.74%) 06/25/20 Fly Intel: After-Hours Movers 05/05/20 Fly Intel: After-Hours Movers BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 09/19/20 Week in review: How Trump's policies moved stocks 08/25/20 Fly Intel: Pre-market Movers 08/15/20 Week in review: How Trump's policies moved stocks ALT Altimmune $12.03 / -0.5 (-3.99%) 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 07/13/20 Fly Intel: After-Hours Movers SAVA NVAX MTN JRJC COST CAMP BMY ALT SAVA Cassava Sciences $9.72 / -0.065 (-0.66%) 09/18/20 Cassava Sciences call volume above normal and directionally bullish 09/14/20 Unusually active option classes on open September 14th 07/24/20 Largest borrow rate increases among liquid names NVAX Novavax $102.48 / +0.92 (+0.91%) 09/15/20 Unusually active option classes on open September 15th 07/08/20 Unusually active option classes on open July 8th 06/24/20 Novavax call volume above normal and directionally bullish 06/15/20 Novavax call volume above normal and directionally bullish MTN Vail Resorts $224.35 / -3.98 (-1.74%) 09/24/20 Vail Resorts options imply 4.4% move in share price post-earnings JRJC China Finance Online $7.48 / -0.27 (-3.48%) 07/20/20 Seven new option listings and eight option delistings on July 20th COST Costco $347.25 / +2.67 (+0.77%) 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th 09/23/20 Unusually active option classes on open September 23rd 07/09/20 Early notable gainers among liquid option names on July 9th CAMP CalAmp $7.90 / -0.14 (-1.74%) 06/25/20 CalAmp options imply 13.6% move in share price post-earnings BMY Bristol-Myers $58.24 / -0.76 (-1.29%) 08/06/20 Unusually active option classes on open August 6th 08/04/20 Bristol Myers Squibb call volume above normal and directionally bullish 07/23/20 Unusually active option classes on open July 23rd 05/01/20 Bristol Myers Squibb put volume heavy and directionally bearish ALT Altimmune $12.03 / -0.5 (-3.99%) 07/29/20 Largest borrow rate increases among liquid names 07/20/20 Altimmune call volume above normal and directionally bullish 07/09/20 Altimmune call volume above normal and directionally bullish 06/12/20 Largest borrow rate increases among liquid names



Earnings China Finance Online reports Q2 EPS (65c) vs. ($1.29) last year » China Finance Online $7.48 / -0.27 (-3.48%) JRJC Reports Q2 revenue $9.7M… Reports Q2 revenue $9.7M vs. $8.9M last year. Q2 gross margin increased to 63.3% from 63.1% last year. CEO Zhiwei Zhao says: "During the second quarter of 2020, the Chinese economy and stock markets staged a strong comeback as the pandemic was mostly contained. As a result of improved market sentiment along with our more effective new marketing programs and extensive products and services provisions, our financial information and advisory business experienced a solid rebound. We further reduced our bottom line loss in the second quarter as our diversified offerings, especially in the personal wealth management category, continued to gain traction, and our ongoing cost control proved to be effective. In the post-COVID era, businesses in China, big and small, are facing unprecedented uncertainties that present both challenges and opportunities. As a professional financial media, we have continued to introduce more innovative marketing strategies that leverage our advantages in media resources and capital market services experience to not only promote more transparent and long-term sustainable development of Chinese capital markets, but also help position publicly listed companies to increase their exposure among investment community and deliver a well-crafted message to investors in this post-COVID era. In September, we successfully hosted two impactful events to bring thought leaders, elite investors and Chinese operators in healthcare and real estate sectors to discuss growth trends and investment opportunities. Our mission remains to help operators share best practices, enterprises deliver long-term values and investors identify the best investment ideas. As the Chinese stock market progresses toward maturity, we are also undertaking our social responsibility to promote long-term investment while we continue to grow our investment advisory services for both institutional and retail investor clients." Show Hide Related Items >> << Company News

Events

Options JRJC China Finance Online $7.48 / -0.27 (-3.48%) 07/16/20 China Finance Online in pact with Dow Jones for Chinese-language news 07/15/20 China Finance Online announces newswire partnership agreement with Dow Jones 04/28/20 China Finance Online announces extension for reporting Q4 results JRJC China Finance Online $7.48 / -0.27 (-3.48%) 07/20/20 Seven new option listings and eight option delistings on July 20th